Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian Cancer.

Computational and mathematical methods in medicine - 1 Jan 2021

Li Ling, Chen Fangfang, Lin An, Wang Di, Shi Yi, Chen Gang

Abstract excerpt

Breast cancer susceptibility genes 1 and 2 (BRCA1 and BRCA2) are known biomarkers for hereditary ovarian cancer (OC). However, a comprehensive association study between BRCA1/2 mutation spectrum and clinicopathological characteristics in Chinese ovarian cancer patients has not been performed yet to our best knowledge. To fill in this gap, we collected BRCA1/2 sequencing data and clinical information of 141 OC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA1 Protein

Share to BRCA2 Protein

Share to Computational Biology

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Ovarian Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 34721658
DOI: 10.1155/2021/4854282
PMCID: PMC8554521

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian Cancer.PMID 34721658Read ↗

[Clinical and familial characterisation of ovarian cancer patients with germline mutations in the BRCA1/2 gene and the current status of prevention in high-risk groups].Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 mutations in ovarian cancer patients from Yunnan Province in southwest China.Semantic proximity Read ↗

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian CancerSemantic proximity Read ↗

BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer.Semantic proximity Read ↗

Analysis and comparison of BRCA1/2 gene mutations in 310 cases of ovarian cancerSemantic proximity Read ↗

Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family.Semantic proximity Read ↗

Prevalence of BRCA1/2 Mutation in High-Grade Non-Mucinous Ovarian Carcinoma.Semantic proximity Read ↗

The expression and mutation of BRCA1/2 genes in ovarian cancer: a global systematic study.Semantic proximity Read ↗

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.Semantic proximity Read ↗

BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study groupSemantic proximity Read ↗

Frequency of mutations in 21 hereditary breast and ovarian cancer susceptibility genes among high-risk Chinese individualsSemantic proximity Read ↗

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.